Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Transaction in Own Shares

17 Nov 2011 17:12

null

Tate & Lyle PLC

Transaction in Own Shares

Tate & Lyle PLC (the "Company") announces that on 17 November 2011 it transferred 11,556 ordinary shares in the Company for the purpose of satisfying exercises under the 2000 Executive Share Option Scheme and the 2003 Performance Share Plan. These shares were previously held in Treasury.

The highest transfer price per share was 325.00p and the lowest transfer price per share was at nil cost.

Following the above transfer, the Company holds 585,104 ordinary shares in Treasury and has 467,565,562 ordinary shares in issue (excluding Treasury shares).

Lucie GilbertDeputy Company Secretary17 November 2011

Copyright Business Wire 2011

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.